| Jill M Cisar, | |
|
1095 Midway Rd, Menasha, WI 54952-1115 | |
| (920) 720-2300 | |
| (920) 720-3806 |
| Full Name | Jill M Cisar |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1095 Midway Rd, Menasha, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043494578 | NPI | - | NPPES |
| 43567900 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 966-121 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jill M Cisar, 1095 Midway Rd, Menasha, WI 54952-1115 Ph: (920) 720-3702 | Jill M Cisar, 1095 Midway Rd, Menasha, WI 54952-1115 Ph: (920) 720-2300 |
News Archive
Implementation Choices for the Children's Health Insurance Program Reauthorization Act of 2009 - This report examines two key areas of the implementation process of the Children's Health Insurance Program Reauthorization Act (CHIPRA) of 2009 - outreach and enrollment, and quality of care - and issues a set of recommendations. "Recommendations include: giving funding priority to states that will adopt or maintain key simplifications… ensuring quality measures focus on priority health needs for children, and building quality measurement and improvement capabilities into electronic health information systems, among others," according to a Commonwealth Fund description of the report (Simpson, Fairbrother, Touschner and Guyer, 9/10).
In a new report published today, ''Susceptibility of Plasmodium Falciparum to Antimalarial Drugs,'' the World Health Organization (WHO) warns that as more and more people gain access to these life-saving malaria medicines, which combine a drug derived from the plant Artemisia annua with a second, synthetic drug, it is vital that countries closely monitor their effectiveness.
American pharmaceutical giant Bristol-Myers Squibb has agreed the purchase of US biotech company Inhibitex, in a $2.5Bn (£1.6bn) deal which includes the promising new anti-hepatitis C drug INX-189, first designed and prepared in Cardiff University.
An analysis of a large nationwide dataset finds that regardless of their socioeconomic status, black women were nearly twice as likely as white women to be diagnosed with triple-negative (TN) breast cancer, a subtype that has a poorer prognosis.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, a monoclonal antibody designed to enhance the immune system by enabling T cells to more effectively attack cancer cells.
› Verified 1 days ago
Ms. Vicki Lee Lafountain, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1478 Kenwood Ctr, Menasha, WI 54952 Phone: 920-886-9319 Fax: 920-886-9357 | |
Willard J Secor Jr., MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1810 Appleton Rd, Menasha, WI 54952 Phone: 920-739-4226 Fax: 920-432-5966 | |
Heather Mattson, MSW, APSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1810 Appleton Rd, Menasha, WI 54952 Phone: 920-739-4226 Fax: 920-739-7639 | |
Ms. Judith Margaret Doersch, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1478 Kenwood Dr, Menasha, WI 54952 Phone: 920-720-5839 | |
Morgan J Gald, MSW, APSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1810 Appleton Rd, Menasha, WI 54952 Phone: 920-739-4226 Fax: 920-432-5966 | |
Ashley Katz, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1478 Kenwood Dr, Suite 1, Menasha, WI 54952 Phone: 920-886-9319 Fax: 920-886-9357 |